Michael B. Hoffman - 19 Aug 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Maria Maccecchini Attorney-in-Fact
Issuer symbol
ANVS
Transactions as of
19 Aug 2025
Net transactions value
+$48,280
Form type
4
Filing time
20 Aug 2025, 17:20:14 UTC
Previous filing
16 Jun 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman Michael B Director C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN /s/ Maria Maccecchini Attorney-in-Fact 20 Aug 2025 0001290208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Award $17,464 +6,717 +0.46% $2.60 1,453,001 19 Aug 2025 Direct
transaction ANVS Common Stock Award $13,683 +5,283 +0.36% $2.59 1,458,284 19 Aug 2025 Direct
transaction ANVS Common Stock Award $14,306 +5,545 +0.38% $2.58 1,463,829 19 Aug 2025 Direct
transaction ANVS Common Stock Award $2,827 +1,100 +0.08% $2.57 1,464,929 19 Aug 2025 Direct
holding ANVS Common Stock 223,357 19 Aug 2025 The 2018 Jane and Michael Hoffman Descendants Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.